Alpha -Tocopherol Acetate Dl- Beta -Carotene Ascor

證據等級: L5

預測適應症: 0 個

Multivitamin-Mineral Combination: Insufficient Data for Repurposing Evaluation

One-Sentence Summary

This submission covers a 15-component multivitamin and mineral combination (including DL-α-Tocopherol Acetate, β-Carotene, Ascorbic Acid, Calcium Carbonate, Cholecalciferol, and 10 additional micronutrients). The TxGNN model returned no predicted indications for this compound, likely because the combination as a whole cannot be resolved to a single DrugBank entity. Without a prediction target, this candidate cannot proceed through standard repurposing evaluation.

Quick Overview

Item	Content
Original Indication	Not available (no regulatory record found)
Predicted New Indication	None — TxGNN returned no predictions
TxGNN Prediction Score	N/A
Evidence Level	N/A — no predictions generated
US Market Status	Not marketed in Taiwan
Number of NDAs	0
Recommended Decision	Hold

Why No Prediction Was Generated

The TxGNN model operates on individual DrugBank-mapped compounds. This submission contains 15 active ingredients submitted as a single semicolon-delimited string, which prevented the pipeline from resolving a DrugBank ID. Without a DrugBank anchor, the knowledge graph cannot generate repurposing candidates.

Each constituent ingredient (e.g., Ascorbic Acid → DrugBank DB00126; Cholecalciferol → DrugBank DB00169; Folic Acid → DrugBank DB00158) is individually mappable and may carry its own repurposing signal. However, the combination as a unit is not modelled.

To generate meaningful predictions, each ingredient should be submitted individually to the TxGNN pipeline.

Safety Considerations

Please refer to the package insert for safety information.

Conclusion and Next Steps

Decision: Hold

Rationale: The pipeline received a multi-ingredient combination string that could not be resolved to a single DrugBank entity, resulting in zero TxGNN predictions and no evaluable evidence. There is no basis for a repurposing recommendation at this time.

To proceed, the following is needed:

Decompose the combination: Re-submit each of the 15 ingredients as separate Evidence Pack queries so that TxGNN can generate per-ingredient predictions.
Resolve DrugBank IDs: Map each INN to its corresponding DrugBank ID before prediction; confirmed mappings exist for most of these micronutrients.
Identify intended original indication: Clarify whether this combination was formulated for a specific clinical use (e.g., nutritional supplementation in a disease population, perioperative support, or a branded multivitamin) so that the original indication field can be populated.
Obtain MOA data: Once individual DrugBank IDs are resolved, mechanism of action data will be retrievable and can support mechanistic plausibility analysis.
Regulatory check: Run individual TFDA queries per ingredient to determine which components hold existing Taiwan licenses and whether a combination product has any prior regulatory history.
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.